Sort
48,018 grants matching “immunotherapy”
(8) Genomic determinants of the T-cell regulome in immune checkpoint blockade
$510,554Tomas Kirchhoff · New York University School Of Medicine · R01 · FY2022 · CA
Targeting Trained Immunity in Trauma-Induced Immune Dysregulation
$510,529James A. Lederer · Brigham And Women'S Hospital · R01 · FY2024 · AI
Targeting Trained Immunity in Trauma-Induced Immune Dysregulation
$510,529James A. Lederer · Brigham And Women'S Hospital · R01 · FY2023 · AI
Targeting Trained Immunity in Trauma-Induced Immune Dysregulation
$510,529James A. Lederer · Brigham And Women'S Hospital · R01 · FY2025 · AI
Molecular Basis of CD1D and Natural Killer T Cell Function
$510,527Sebastian Joyce · Vanderbilt University Medical Center · R01 · FY2022 · AI
Project 1: Combinatorial adjuvants promote uniform and selective intratumoral CTL infiltration in colorectal cancer
$510,510Pawel Kalinski · Roswell Park Cancer Institute Corp · P01 · FY2021 · CA
Understanding and Overcoming Resistance to BRAF/MEK Kinase Inhibitors in Melanoma
$510,510Arjun Raj · University Of Pennsylvania · R01 · FY2021 · CA
Establishing the role of MMP9 in amyloid-immunotherapy-induced ARIA
$510,498Donna M. Wilcock · Indiana University Indianapolis · R01 · FY2025 · NS
Map Leukemia-immune Cell Talks with Nanoplasmon Ruler in CAR T-Cell Immunotherapy
$510,476Weiqiang Chen · New York University · R01 · FY2023 · CA
B7-H1/PD-1 modulation in cancer therapy
$510,450Drew M. Pardoll · Johns Hopkins University · R01 · FY2010 · CA
IONIC MECHANISMS OF RESISTANCE TO IMMUNOTHERAPY IN HEAD AND NECK CANCER
$510,442Childrens Hospital Medical Center · · FY2017 · Department of the Army
Therapeutic Targeting of Immune Evasion from the MICA - NKG2D Pathway
$510,440Kai W Wucherpfennig · Dana-Farber Cancer Inst · R01 · FY2022 · CA
Therapeutic Targeting of Immune Evasion from the MICA - NKG2D Pathway
$510,440Kai W Wucherpfennig · Dana-Farber Cancer Inst · R01 · FY2023 · CA
Biodynamic Imaging of Drug Resistance in Living Tissue
$510,413David D Nolte · Purdue University · · FY2019 · ENG
Resource for Nonhuman Primate Immune Reagents
$510,411Francois J Villinger · Emory University · R24 · FY2011 · RR
Divergent Roles of MerTK,Tyro3, and Axl in Pancreatic Cancer and Metastasis
$510,409Henry Shelton Earp · Univ Of North Carolina Chapel Hill · R01 · FY2024 · CA
CAREER: Glycoprotein mimetics with tailored galectin-binding properties based on self-assembled glycopeptide nanofibers
$510,218Gregory A Hudalla · University Of Florida · · FY2015 · MPS
Steroid nuclear receptor coactivators in T cell differentiation
$510,194Zuoming Sun · Beckman Research Institute/City Of Hope · R01 · FY2023 · AI
Steroid nuclear receptor coactivators in T cell differentiation
$510,194Zuoming Sun · Beckman Research Institute/City Of Hope · R01 · FY2021 · AI
Steroid nuclear receptor coactivators in T cell differentiation
$510,194Zuoming Sun · Beckman Research Institute/City Of Hope · R01 · FY2020 · AI
Steroid nuclear receptor coactivators in T cell differentiation
$510,194Zuoming Sun · Beckman Research Institute/City Of Hope · R01 · FY2019 · AI
Steroid nuclear receptor coactivators in T cell differentiation
$510,194Zuoming Sun · Beckman Research Institute/City Of Hope · R01 · FY2022 · AI
Role of immune receptor clustering in controlling efficacy of antibody-dependent FcγRIIIa-mediated cytotoxicity by NK cells
$510,193Yuri Sykulev · Thomas Jefferson University · U01 · FY2021 · AI
The Adenosinergic Pathway in Tumor-derived Exosomes
$510,187Theresa L. Whiteside · University Of Pittsburgh At Pittsburgh · R01 · FY2021 · CA
Clinical protocols for the treatment of gastrointestinal cancer
$510,185Tim Greten · Division Of Basic Sciences - Nci · ZIA · FY2022 · CA